Advanced Hematologic Malignancy
1 clinical trials · Condition
◉ Watch Advanced Hematologic Malignancy
| Record | Firm | Date |
|---|---|---|
| FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies (NCT04891757) | Foghorn Therapeutics Inc. | 2021-06-14 |
Track Advanced Hematologic Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.